There’s no shortage of research illustrating the disastrous impact that price controls have on consumer welfare and the broader economy.
The Democrats’ days in control of federal healthcare policy are numbered. But they were able to do quite a bit of damage during President Biden’s term.
The scheme of price controls they’ve put in place for drugs dispensed through Medicare is a case in point. Ten drugs in Medicare Part D will be subject to price controls starting in 2026. More will be ensnared in every subsequent year.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
Yet More Evidence That Price Controls Are Bad For Patients
Sally C. Pipes
There’s no shortage of research illustrating the disastrous impact that price controls have on consumer welfare and the broader economy.
The Democrats’ days in control of federal healthcare policy are numbered. But they were able to do quite a bit of damage during President Biden’s term.
The scheme of price controls they’ve put in place for drugs dispensed through Medicare is a case in point. Ten drugs in Medicare Part D will be subject to price controls starting in 2026. More will be ensnared in every subsequent year.
Read the entire Forbes op-ed here.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.